Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Apr 10, 2025
- Accession no.
- 0001447362-25-000059
- Filed
- Apr 10, 2025
- Trade date
- Apr 8-9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $113.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2025 | Common Stock | SSaleDisposed | −213 | $20.03F2 | −$4,266.39 | 76,886 | Direct | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −348 | $20.03F2 | −$6,970.44 | 64,677 | Indirect | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −299 | $20.03F2 | −$5,988.97 | 55,073 | Indirect | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −30 | $20.03F2 | −$600.9 | 4,578 | Indirect | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −28 | $20.03F2 | −$560.84 | 4,577 | Indirect | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −28 | $20.03F2 | −$560.84 | 4,577 | Indirect | |
| Apr 8, 2025 | Common Stock | SSaleDisposed | −28 | $20.03F2 | −$560.84 | 4,577 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −1,023 | $20.22F9 | −$20,685.06 | 75,863 | Direct | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −1,669 | $20.22F9 | −$33,747.18 | 63,008 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −1,432 | $20.22F9 | −$28,955.04 | 53,641 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −135 | $20.22F9 | −$2,729.7 | 4,443 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −137 | $20.22F9 | −$2,770.14 | 4,440 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −137 | $20.22F9 | −$2,770.14 | 4,440 | Indirect | |
| Apr 9, 2025 | Common Stock | SSaleDisposed | −137 | $20.22F9 | −$2,770.14 | 4,440 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.000 to $20.090, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $20.000 to $20.665, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.